MaxCyte Announces Launch of Offering and Application to List on the Nasdaq Global Market

GAITHERSBURG, Md., July 26, 2021 /PRNewswire/ — MaxCyte, Inc., (LSE: MXCT) (LSE: MXCN), a leading provider of platform technologies for cell engineering, today announced the commencement of an underwritten offering of 12,000,000 shares of common stock (the “Offering”) at an expected…

About the Author

has written 41555 stories on this site.

Copyright © 2010 Business and Corporate News.